We are live on ! Find out more
SFI

Sonic Fund II Portfolio holdings

AUM $147M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+69.01%
1 Year Est. Return
-19.98%
3 Year Est. Return
+119.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.4M
AUM Growth
–
Cap. Flow
+$81M
Cap. Flow %
83.22%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ADVM
Adverum Biotechnologies
ADVM
+$35.6M
2
RGNX icon
Regenxbio
RGNX
+$18.4M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$11.4M
4
GNW icon
Genworth Financial
GNW
+$8.82M
5
FENC icon
Fennec Pharmaceuticals
FENC
+$4.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.92%
2 Financials 11.93%
3 Materials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADVM
1
DELISTED
Adverum Biotechnologies
ADVM
$46.6M 47.83%
+404,321
New +$35.6M
RGNX icon
2
Regenxbio
RGNX
$616M
$19.1M 19.59%
+465,664
New +$18.4M
SRPT icon
3
Sarepta Therapeutics
SRPT
$1.64B
$14.5M 14.93%
+112,689
New +$11.4M
GNW icon
4
Genworth Financial
GNW
$3.86B
$9.23M 9.48%
+2,097,335
New +$8.82M
FENC icon
5
Fennec Pharmaceuticals
FENC
$335M
$5.42M 5.56%
+834,689
New +$4.48M
SPNT icon
6
SiriusPoint
SPNT
$3.03B
$2.39M 2.45%
+227,185
New +$2.21M
TROX icon
7
Tronox
TROX
$967M
$149K 0.15%
+13,055
New +$130K

Similar funds

JAMH
Junson Asset Management (HK) Hong Kong $147M AUM 33.59% 1-Year Est. Return
MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
AEPBI
AH Equity Partners Bio II Menlo Park, California $144M AUM 54.61% 1-Year Est. Return
SC
Siena Capital Cincinnati, Ohio $153M AUM 9% 1-Year Est. Return
HGM
Highside Global Management Dallas, Texas $136M AUM 36.73% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
SP
StackLine Partners New York $134M AUM 35.15% 1-Year Est. Return
HCM
HM Capital Management Clayton, Missouri $167M AUM 9.14% 1-Year Est. Return

Sonic Fund II's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Sonic Fund II, which disclosed 7 positions worth $97.4M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Adverum Biotechnologies: 404,321 shares worth $46.6M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, followed by Financials and Materials.

  • Sonic Fund II's largest Q4 2019 buy was Adverum Biotechnologies: 404,321 shares worth $46.6M.
  • Sonic Fund II's ten largest holdings make up 100% of its $97.4M portfolio in Q4 2019.
  • Sonic Fund II disclosed 7 positions in Q4 2019, its first 13F filing on record.

Based on Sonic Fund II's 13F filing for Q4 2019, filed 14 Feb 2020.